Abstract:Abstract Cancer-derived circulating miRNAs represent a promising new class of circulating biomarkers for cancer detection, prognosis, and therapeutic targets. We analyzed the differential c-miRNA expression levels of ∼100 candidate serum miRNAs by quantitative RT-PCR in 174 Caucasian, early stage lung cancer patients and 184 Caucasian healthy controls. Serum miR152 exhibited significant differential expression between cases and controls (P = 0.014). Low levels of serum miR152 expression were consistently associated with an increased risk of lung cancer. The down-regulated miR152 expression was also detected across a panel of 40 NSCLC and normal bronchial epithelial cell lines and in 250 primary tumors by miRNA expression profiling on microarrays. The tumor-derived origin of the c-miR150 was confirmed by an increased level of serum miR152 with increased tumor volumes three weeks after tumor cell inoculation in a human H1299 tumor xenograft mouse model by qRT-PCR assay. Ectopic expression of miR-152 suppressed tumor cell proliferation, colony formation, and cell migration/invasion in NSCLC H1299, H460, and A549 cells transfected by miR-152 expression plasmids. Inhibition of miR-152 expression by a miR-152 inhibitor promoted tumor cell proliferation in HCC15 cells. Overexpression of miR152 in H1299, H460 and A549 cells significantly down-regulated the constitutive expression of the DNMT1 miR-152 target gene and protein, suggesting its potential role in the epigenetic regulation of lung cancer pathogenesis. These results suggest that serum miR-152 may serve as a novel negative predictor for lung cancer risk, recurrence, and survival in early stage NSCLC and function as a potential tumor suppressor miRNA by epigenetic down-regulation of oncogenesis.(This study is partially supported by NIH/NCI grants Lung SPORE 5P50CA070907 and R01CA176568, a CPRIT Grant and a MDACC Moonshot Program Grant) Citation Format: Taro Oba, Yuanqing Ye, Liren Zhang, Jing Lin, Emanuela Gentile, Jing Wang, Yang Zhao, Jiang Gu, Ignacio Wistuba, Jack A. Roth, Xifeng Wu, Lin Ji. Serum miR152 as a novel prognostic biomarker and potential tumor suppressor for early stage non-small cell lung cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1115.

MicroRNA-383 is a Tumor Suppressor and Potential Prognostic Biomarker in Human Non-Small Cell Lung Caner.

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Identification of Microrna-615-3p As a Novel Tumor Suppressor in Non-Small Cell Lung Cancer.

Deregulated Expression of Mir-21, Mir-143 and Mir-181A in Non Small Cell Lung Cancer is Related to Clinicopathologic Characteristics or Patient Prognosis

miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2

MicroRNA-125a-3p Downregulation Correlates with Tumorigenesis and Poor Prognosis in Patients with Non-Small Cell Lung Cancer

Potential Use of Microrna-200C As a Prognostic Marker in Non-Small Cell Lung Cancer.

Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer.

Reduced Mir-105-1 Levels Are Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer.

Mir-1225-5p Inhibits Non-Small Cell Lung Cancer Cell Proliferation, Migration and Invasion, and May Be a Prognostic Biomarker.

MicroRNA-218 Functions As a Tumor Suppressor in Lung Cancer by Targeting IL-6/STAT3 and Negatively Correlates with Poor Prognosis

MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients

Abstract 1115: Serum Mir152 As a Novel Prognostic Biomarker and Potential Tumor Suppressor for Early Stage Non-Small Cell Lung Cancer

Prognostic Implications of Decreased Microrna-101-3p Expression in Patients with Non-Small Cell Lung Cancer

Downregulation of Hsa-Microrna-204-5p and Identification of Its Potential Regulatory Network in Non-Small Cell Lung Cancer: RT-qPCR, Bioinformatic- and Meta-Analyses.

Down-regulation of Microrna-144-3p and Its Clinical Value in Non-Small Cell Lung Cancer: a Comprehensive Analysis Based on Microarray, Mirna-Sequencing, and Quantitative Real-Time PCR Data

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

Expression and Clinical Significance of Mir-139-5p in Non-Small Cell Lung Cancer

Mir-638 is A New Biomarker for Outcome Prediction of Non-Small Cell Lung Cancer Patients Receiving Chemotherapy

MicroRNA-383: A tumor suppressor miRNA in human cancer

Up-Regulation Of Microrna-93 Predicates Advanced Clinicopathological Features And Serves As An Unfavorable Risk Factor For Survival Of Patients With Non-Small Cell Lung Cancer